Meet Professor Derek Richard
A big part of the Ellus & Krue story involves our partnership with the Cancer & Ageing Research Foundation. Professor Derek Richard works with an internationally regarded research team dedicated to curing cancer. Their goal is to develop a universal cancer treatment that may also positively impact ageing diseases such as Alzheimer’s. His work also extends to Ellus & Krue, through his collaboration with us to create the EPI-gN™ Serum.
We sat down with Professor Derek and asked him about his research and what it means for skincare.
What is the process of ageing?
Ageing is a completely natural process. The underlying cause of ageing is genetic damage, which effects our epigenetics. When most people turn 40 years old their cells start to switch off the DNA repair processes, meaning genetic damage to our genome occurs at a faster rate and this can lead to diseases such as cancer, Alzheimer’s and osteoporosis. Ageing is most noticeable in your face when the damaged skin cells stop producing elastin and collagen, resulting in a slackening of the skin.
What is the relationship between sun damage and ageing?
Sun damage causes mutations within your genetic code and skin cells by making cells less fit and not function properly, so you start to look older. Applying sunscreen filters out UV light, so when the UV hits your skin it’s filtered out before it hits the genetic code of your cells. UV light is associated with rapid ageing of skin and that’s why people who spend lots of time outdoors with no sunscreen look older.
What does it mean to partner with Ellus & Krue?
Our partnership with Ellus & Krue is amazing. From the sale of Ellus & Krue products, we are going to have funds flowing back to the laboratory, fundamental research, funding clinical trials and making a really big difference. We are developing therapeutics that reduce the risk of cancer and reduce the risk of getting diseases such as Alzheimer’s, but this costs millions of dollars to fund. We are launching a cutting edge product with the EPI-gN™ Serum. It has taken over a year to formulate, so it contains not only the right ingredients but also enough of those ingredients to produce real results.The serum really enhances and improves the look and feel of your skin and reduces the appearance of fine lines and wrinkles.
What does your research mean for skincare?
After the age of 40 our risk of getting cancer doubles every year until around the age of 85. If we get cancer, those cells become immortal, effectively they live forever. Our first therapeutic is designed to hit that switch and make them mortal again. The genetic code falls to pieces after our therapeutic treats them, and they die because they aged so rapidly.
The other therapeutic we are developing is designed to slow down the ageing process. Rather than our body switching off the repair system that looks after the genetic code, we switch it back on. The effect of our therapeutic will be to reduce the appearance of ageing, so you won’t have the rapid ageing appearance after the age of 40-45 and will feel healthier and have a better quality of life.
What is the future of ageing?
Well it’s going to be transformative in the next ten years. We know it’s a treatable condition, and if we can treat it early enough, we will transform people’s lives. The first therapeutics will hit the market and hopefully it's ours. We understand that ageing can be slowed, and our quality of life can be increased.